Intestinal Failure
33
4
6
18
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.0%
1 terminated out of 33 trials
94.7%
+8.2% vs benchmark
6%
2 trials in Phase 3/4
6%
1 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 18 completed trials
Clinical Trials (33)
Resting Energy Expenditure by Gastrointestinal Functional Status
Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration.
Weaning is Winning? (WeWin Study)
8.4% Sodium Bicarbonate Locks in Intestinal Failure
Video Training Supplementation for Patients Discharged on Home Parental Nutrition
CGM-Assisted Management of PN
The LIFT-ECHO Last Mile Project
Anabolic Response To Intravenous Amino Acids In Chronic Intestinal Failure Patients
AI-driven Total Parenteral Nutrition Platform
Chyme Reinfusion for Type 2 Intestinal Failure
Optimised Osmolality in Oral Supplements Optimised Osmolality in Oral Supplements
Effect of Parenteral Support on FibroScan in Short Bowel Syndrome
Effect of Parenteral Nutrition With n-3 PUFAs on Patients With Intestinal Failure
Risk Factors for Catheter-Related Bloodstream Infections in Hospitalized Intestinal Failure Patients
Effect of Vitamin D on Skeletal Muscle Function and Qol in Patients With Chronic Intestinal Failure/Insufficiency
Changing the Future of Intestinal Failure in Intestinal Chronic Inflammation (INT-FAIL)
Spectral Lighting and Intestinal Failure
Overview of Botriomycoma in Children with a Central Line: Epidemiology, Risk Factors, Treatments
Clinical Trial Comparing TaurolockTMHep100 (Taurolidine 1.35%) and 0.9% Saline As Prevention of Recurrent Catheter-related Bloodstream Infections
Level of Deprivation Assessment in a Population of Short-bowel Syndrome Patients With Intestinal Failure